LD-2 disclosure · 2nd Quarter - Report
PERSONALIZED MEDICINE COALITION
Client
- Description
- Health care
- Location
- District of Columbia · United States of America
Registrant
- Description
- education and advocacy
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
Congressional Personalized Medicine Caucus Precision Medicine Answers for Kids Today Act/Ending the Diagnostic Odyssey Act Seniors Timely Access to Care Act FDA Rulemaking on Laboratory Developed Tests Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Collaborative Community CMS Implementation of Medicare Drug Price Negotiation Program CMS Final Rule Misclassification of Drugs, Program Administration and Program Integrity Updates under the Medicaid Drug Rebate Program (MDRP) CMS Inpatient Prospective Payment System (IPPS) reimbursement for low-volume rare disease treatments and CAR T Cell Therapies
LobbyistsCYNTHIA BENS · DAVID L DAVENPORT
Covered position (CYNTHIA BENS): Staff, Representative Paul E. Kanjorski
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)
Budget/Appropriations
FY 2025 Food and Drug Administration Budget Priorities for CDER, CBER and CDRH FY 2025 National Institutes of Health Budget Priorities
LobbyistsCYNTHIA BENS
Covered position (CYNTHIA BENS): Staff, Representative Paul E. Kanjorski
TargetedSENATE · HOUSE OF REPRESENTATIVES